683 Capital Management, LLC - Q3 2015 holdings

$680 Million is the total value of 683 Capital Management, LLC's 86 reported holdings in Q3 2015. The portfolio turnover from Q2 2015 to Q3 2015 was 0.0% .

 Value Shares↓ Weighting
 SUPERNUS PHARMACEUTICALS INCnote 7.500% 5/0$13,844,000
-16.8%
4,962,0000.0%2.04%
-41.0%
LUK  LEUCADIA NATL CORP$11,143,000
-16.6%
550,0000.0%1.64%
-40.9%
 FXCM INCnote 2.250% 6/1$6,660,000
-12.2%
9,000,0000.0%0.98%
-37.7%
 GEVO INCnote 7.500% 7/0$4,712,000
-18.3%
10,025,0000.0%0.69%
-42.1%
KKR  KKR & CO L P DEL$4,119,000
-26.6%
245,5000.0%0.61%
-47.9%
 VIPSHOP HLDGS LTDnote 1.500% 3/1$3,342,000
-12.3%
3,000,0000.0%0.49%
-37.8%
MDT  MEDTRONIC PLC$2,477,000
-9.7%
37,0080.0%0.36%
-36.0%
SNC  STATE NATL COS INC$2,384,000
-13.7%
255,0000.0%0.35%
-38.7%
GLMD  GALMED PHARMACEUTICALS LTD$1,966,000
-26.1%
264,6000.0%0.29%
-47.6%
AGRO  ADECOAGRO S A$1,944,000
-13.7%
244,2300.0%0.29%
-38.8%
SLV  ISHARES SILVER TRUSTishares$1,872,000
-7.7%
135,0000.0%0.28%
-34.7%
SLV  ISHARES SILVER TRUSTput$1,872,000
-7.7%
135,0000.0%0.28%
-34.7%
FSAM  FIFTH STR ASSET MGMT INC$1,793,000
-27.3%
240,0000.0%0.26%
-48.4%
AMTG  APOLLO RESIDENTIAL MTG INC$1,785,000
-13.8%
141,0000.0%0.26%
-38.8%
KEN  KENON HLDGS LTD$1,715,000
-33.7%
130,0000.0%0.25%
-53.1%
GM  GENERAL MTRS CO$1,489,000
-9.9%
49,6000.0%0.22%
-36.2%
DPRX  DIPEXIUM PHARMACEUTICALS INC$980,000
+10.1%
70,0000.0%0.14%
-22.2%
PTIE  PAIN THERAPEUTICS INC$791,000
+5.7%
432,1280.0%0.12%
-25.2%
KODK  EASTMAN KODAK CO$717,000
-7.0%
45,9200.0%0.10%
-34.4%
KNDI  KANDI TECHNOLOGIES GROUP INCput$630,000
-41.9%
120,0000.0%0.09%
-58.7%
MDLY  MEDLEY MGMT INC$566,000
-44.1%
85,5370.0%0.08%
-60.5%
ORM  OWENS RLTY MTG INC$324,000
-8.2%
23,5240.0%0.05%
-34.2%
IMI  INTERMOLECULAR INC$212,000
-4.1%
112,1290.0%0.03%
-32.6%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
IRSA INVERSIONES Y REP S A42Q3 20232.9%
CRESUD S A C I F Y A39Q3 20233.3%
ENOVA INTL INC34Q3 20238.2%
UNIQURE NV28Q3 20234.1%
INSPIRED ENTMT INC28Q3 20232.3%
MICRON TECHNOLOGY INC26Q1 20233.2%
GALMED PHARMACEUTICALS LTD25Q1 20201.2%
FENNEC PHARMACEUTICALS INC25Q3 20230.9%
CARVANA CO24Q3 202314.2%
ALNYLAM PHARMACEUTICALS INC24Q2 20223.2%

View 683 Capital Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
683 Capital Management, LLC Q3 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
AxonPrime Infrastructure Acquisition CorpFebruary 14, 2023441,1382.9%
DIRTT ENVIRONMENTAL SOLUTIONS LTDFebruary 14, 2023218,490-
Hawks Acquisition CorpFebruary 14, 20231,979,5928.6%
MARINUS PHARMACEUTICALS, INC.February 14, 202390,0000.2%
SQZ Biotechnologies CoFebruary 14, 20231,330,8894.5%
Trajectory Alpha Acquisition Corp.February 14, 20231,484,7998.6%
Concord Acquisition CorpSeptember 26, 20221,550,6495.5%
Archer Aviation Inc.Sold outFebruary 14, 202200.0%
Hippo Holdings Inc.Sold outFebruary 14, 202200.0%
Joby Aviation, Inc.Sold outFebruary 14, 202200.0%

View 683 Capital Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-06-24
13F-HR2024-05-15
SC 13G2024-03-01
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View 683 Capital Management, LLC's complete filings history.

Compare quarters

Export 683 Capital Management, LLC's holdings